Davis, J
Maes, M
Andreazza, A
McGrath, J J
Tye, S J
Berk, M
Article History
Received: 16 April 2014
Revised: 12 September 2014
Accepted: 17 September 2014
First Online: 28 October 2014
Competing interests
: MB has been a speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck, Merck, Pfizer, Sanofi Synthelabo, Servier, Solvay and Wyeth, and served as a consultant to Astra Zeneca, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Cilag, Lundbeck and Servier. The remaining authors declare no conflict of interest.